Abstract
Matrix metalloproteinase-9 (MMP-9) plays an important role in the invasion and metastasis of cancer cells. In this study, we examined the inhibitory effect of bee venom (BV) and its major peptides, melittin and apamin, on PMA-induced invasion induced by MMP-9 expression in Caki-1 renal cancer cells. BV and melittin, but not apamin, significantly suppressed PMA-induced invasion by inhibiting MMP-9 expression in Caki-1 cells. Furthermore, as evidenced by MMP-9 promoter assays, melittin inhibited MMP-9 gene expression by blocking the PMA-stimulated activations of activator protein-1 (AP-1) and nuclear factor-kappa B (NF-κB). In addition, melittin suppressed the PMA-induced phosphorylations of ERK and JNK mitogenactivated protein kinases, upstream factors involved in Ap-1 and NF-κB. These results suggest that the suppression of MMP-9 expression contributes to the anti-tumor properties of melittin.
References
Benelli, R., Adatia, R., Ensoli, B., Stetler-Stevenson, W.G., Santi, L., Albini, A. (1994). Inhibition of AIDS-Kaposi’s sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. Oncol. Res. 6, 251–257.
Chae, Y.M., Park, K.K., Magae, J., Lee, I.S., Kim, C.H., Kim, H.C., Hong, S., Lee, J.G., Choi, I.J., Chang, Y.C., et al. (2004). Sp1-decoy oligodeoxynucleotide inhibits high glucose-induced mesangial cell proliferation. Biochem. Biophys. Res. Commun. 319, 550–555.
Chambers, A.F., and Matrisian, L.M., (1997). Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89, 260–270.
Cho, B.J., Im, E.K., Kwon, J.H., Lee, K.H., Shin, H.J., Oh, J., Kang, S.M., Chung, J.H., and Jang, Y. (2005). Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells. Mol. Cells 20, 429–434.
Cho, H.J., Kang, J.H., Kwak, J.Y., Lee, T.S., Lee, I.S., Park, N.G., Nakajima, H., Magae, J., and Chang, Y.C. (2007). Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis 28, 1104–1110.
Chu, S.T., Cheng, H.H., Huang, C.J., Chang, H.C., Chi, C.C., Su, H.H., Hsu, S.S., Wang, J.L., Chen, I.S., Jan, C.R., et al. (2007). Phospholipase A2-independent Ca2+ entry and subsequent apoptosis induced by melittin in human MG63 osteosarcoma cells. Life Sci. 80, 364–369.
De Clerck, Y.A., Darville, M.I., Eeckhout, Y., and Rousseau, G.G. (1994). Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene 139, 185–191.
Dempsey, C.E. (1990). The actions of melittin on membranes. Biochim. Biophys. Acta 1031, 143–161.
Eberhardt, W., Huwiler, A., Beck, K.F., Walpen, S., and Pfeilschifter, J. (2000). Amplification of IL-1 beta-induced matrix metalloproteinase 9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J. Immunol. 165, 5788–5797.
Gevod, V.S., and Birdi, K.S. (1984). Melittin and the 8–26 fragment. Differences in ionophoric properties as measured by monolayer method. Biophys. J. 45, 1079–1083.
Gum, R., Lengyel, E., Juarez, J., Chen, J.H., Sato, H., Seiki, M., and Boyd, D. (1996). Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem. 271, 10672–10680.
Gum, R., Wang, H., Lengyel, E., Juarez, J., and Boyd, D. (1997). Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14, 1481–1493.
Hider, R.C. (1988). Honeybee venom: a rich source of pharmacologically active peptides. Endeavour 12, 60–65.
Hong, S., Park, K.K., Magae, J., Ando, K., Lee, T.S., Kwon, T.K., Kwak, J.Y., Kim, C.H., and Chang, Y.C. (2005). Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells. J. Biol. Chem. 280, 25202–25209.
Jang, M.H., Shin, M.C., Lim, S., Han, S.M., Park, H.J., Shin, I., Lee, J.S., Kim, K.A., Kim, E.H., and Kim, C.J. (2003). Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299. J. Pharmacol. Sci. 91, 95–104.
Kohler, M., Hirschberg, B., Bond, C.T., Kinzie, J.M., Marrion, N.V., Maylie, J., and Adelman, J.P. (1996). Small-conductance, calcium-activated potassium channels from mammalian brain. Science 273, 1709–1714.
Kwon, Y.B., Lee, J.D., Lee, H.J., Han, H.J., Mar, W.C., Kang, S.K., Beitz, A.J., and Lee, J.H. (2001). Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain 90, 271–280.
Kwon, Y.B., Lee, H.J., Han, H.J., Mar, W.C., Kang, S.K., Yoon, O.B., Beitz, A.J., and Lee, J.H. (2002). The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci. 71, 191–204.
Lakka, S.S., Gondi, C.S., Yanamandra, N., Olivero, W.C., Dinh, D.H., Gujrati, M., and Rao, J.S. (2004). Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23, 4681–4689.
Lee, S.J., Sakurai, H., Oshima, K., Kim, S.H., and Saiki, I. (2003). Anti-metastatic and anti-angiogenic activities of a new matrix metalloproteinase inhibitor, TN-6b. Eur. J. Cancer 39, 1632–1641.
Lee, S.O., Jeong, Y.J., Im, H.G., Kim, C.H., Chang, Y.C., and Lee, I.S. (2007). Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. Biochem. Biophys. Res. Commun. 354, 165–171.
Lein, M., Jung, K., Laube, C., Hubner, T., Winkelmann, B., Stephan, C., Hauptmann, S., Rudolph, B., Schnorr, D., and Loening, S.A. (2000). Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma. Int. J. Cancer 85, 801–804.
Lin, C.W., Hou, W.C., Shen, S.C., Juan, S.H., Ko, C.H., Wang, L.M., and Chen, Y.C. (2008). Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 29, 1807–1815.
Moon, D.O., Park, S.Y., Heo, M.S., Kim, K.C., Park, C., Ko, W.S., Choi, Y.H., and Kim, G.Y. (2006). Key regulators in bee venominduced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt. Int. Immunopharmacol. 6, 1796–1807.
Moon, D.O., Park, S.Y., Choi, Y.H., Kim, N.D., Lee, C., and Kim, G.Y. (2008). Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells. Toxicon 51, 112–120.
Nabeshima, K., Inoue, T., Shimao, Y., and Sameshima, T. (2002). Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol. Int. 52, 255–264.
Nah, S.S., Ha, E., Lee, H.J., and Chung, J.H. (2007). Inhibitory effects of melittin on the production of lipopolysaccharideinduced matrix metalloproteinase 3 in human osteoarthritic chondrocytes. Toxicon 49, 881–885.
Nakshatri, H., Bhat-Nakshatri, P., Martin, D.A., Goulet, Jr. R.J., and Sledge, Jr. G.W. (1997). Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17, 3629–3639.
Orsolic, N., Sver, L., Verstovsek, S., Terzic, S., and Basic, I. (2003). Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom. Toxicon 41, 861–870.
Park, D., Shim, E., Kim, Y., Kim, Y.M., Lee, H., Choe, J., Kang, D., Lee, YS., and Jeoung, D. (2008). C-FLIP promotes the motility of cancer cells by activating FAK and ERK, and increasing MMP-9 expression. Mol. Cells 25, 184–195.
Ray, J.M., and Stetler-Stevenson, W.G. (1994). The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Respir. J. 7, 2062–2072.
Sato, H., and Seiki, M. (1993). Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8, 395–405.
Shishodia, S., Majumdar, S., Banerjee, S., and Aggarwal, B.B. (2003). Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of Ikappa-Balpha kinase and p65 phosphorylation: correlation with downregulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 63, 4375–4383.
Simon, C., Goepfert, H., and Boyd, D. (1998). Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res. 58, 1135–1139.
Son, Y.O., Lee, K.Y., Choi, K.C., Chung, Y., Kim, J.G., Jeon, Y.M., Jang, Y.S., and Lee, J.C. (2004). Inhibitory effects of glycoprotein-120 (G-120) from Ulmus davidiana Nakai on cell growth and activation of matrix metalloproteinases. Mol. Cells 18, 163–170.
Son, D.J., Ha, S.J., Song, H.S., Lim, Y., Yun, Y.P., Lee, J.W., Moon, D.C., Park, Y.H., Park, B.S., Hong, J.T., et al. (2006). Melittin inhibits vascular smooth muscle cell proliferation through induction of apoptosis via suppression of nuclear factor-kappaB and Akt activation and enhancement of apoptotic protein expression. J. Pharmacol. Exp. Ther. 317, 627–634.
Son, D.J., Lee, J.W., Lee, Y.H., Song, H.S., Lee, C.K., and Hong, J.T. (2007). Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol. Ther. 115, 246–270.
Stetler-Stevenson, W.G., Brown, P.D., Onisto, M., Levy, A.T., and Liotta, L.A. (1990). Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 265, 13933–13938.
Stetler-Stevenson, W.G., Hewitt, R., and Corcoran, M. (1996). Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin. Cancer Biol. 7, 147–154.
Wang, C., Chen, T., Zhang, N., Yang, M., Li, B., Lü, X., Cao, X., and Ling, C. (2009). Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting IkappaBalpha kinase-NFkappaB. J. Biol. Chem. 284, 3804–3813.
Woo, M.S., Jung, S.H., Kim, S.Y., Hyun, J.W., Ko, K.H., Kim, W.K., and Kim, H.S. (2005). Curcumin suppresses phorbol esterinduced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem. Biophys. Res. 335, 1017–1025.
Zucker, S., Lysik, R.M., Zarrabi, M.H., and Moll, U. (1993). M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res. 53, 140–146.
Zucker, S., Cao, J., and Chen, W.T. (2000). Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 19, 6642–6650.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Park, J.H., Jeong, YJ., Park, KK. et al. Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-κB and AP-1-dependent MMP-9 expression. Mol Cells 29, 209–215 (2010). https://doi.org/10.1007/s10059-010-0028-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-010-0028-9